149 related articles for article (PubMed ID: 18591216)
1. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Vali M; Vossen JA; Buijs M; Engles JM; Liapi E; Ventura VP; Khwaja A; Acha-Ngwodo O; Ganapathy-Kanniappan S; Syed L; Wahl RL; Geschwind JF
J Pharmacol Exp Ther; 2008 Oct; 327(1):32-7. PubMed ID: 18591216
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
[TBL] [Abstract][Full Text] [Related]
4. [Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits].
Jiang XY; Zhang XP; Huang JH; Luo RG; Miao BJ; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(39):3139-42. PubMed ID: 24417996
[TBL] [Abstract][Full Text] [Related]
5. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
6. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Vossen JA; Buijs M; Syed L; Kutiyanwala F; Kutiyanwala M; Geschwind JF; Vali M
Clin Exp Metastasis; 2008; 25(7):811-7. PubMed ID: 18649116
[TBL] [Abstract][Full Text] [Related]
7. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
8. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
9. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer.
Buijs M; Vossen JA; Geschwind JF; Ishimori T; Engles JM; Acha-Ngwodo O; Wahl RL; Vali M
Invest New Drugs; 2009 Apr; 27(2):120-3. PubMed ID: 18553054
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
[TBL] [Abstract][Full Text] [Related]
12. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Geschwind JF; Ko YH; Torbenson MS; Magee C; Pedersen PL
Cancer Res; 2002 Jul; 62(14):3909-13. PubMed ID: 12124317
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
Schaefer NG; Geschwind JF; Engles J; Buchanan JW; Wahl RL
Transl Res; 2012 Jan; 159(1):51-7. PubMed ID: 22153810
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.
Chapiro J; Sur S; Savic LJ; Ganapathy-Kanniappan S; Reyes J; Duran R; Thiruganasambandam SC; Moats CR; Lin M; Luo W; Tran PT; Herman JM; Semenza GL; Ewald AJ; Vogelstein B; Geschwind JF
Clin Cancer Res; 2014 Dec; 20(24):6406-17. PubMed ID: 25326230
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Intra-arterial Delivery of a "Trojan-horses" Gene Therapy: A Pilot Study on Rabbit VX2 Hepatic Tumor Model.
Pellerin O; Amara I; Sapoval M; Méachi T; Déan C; Beaune P; de Waziers I
Cardiovasc Intervent Radiol; 2018 Jan; 41(1):153-162. PubMed ID: 29090347
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model.
Kunjithapatham R; Geschwind JF; Rao PP; Boronina TN; Cole RN; Ganapathy-Kanniappan S
BMC Res Notes; 2013 Jul; 6():277. PubMed ID: 23866825
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer.
Ota S; Geschwind JF; Buijs M; Wijlemans JW; Kwak BK; Ganapathy-Kanniappan S
Target Oncol; 2013 Jun; 8(2):145-51. PubMed ID: 23529644
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET.
Oya N; Nagata Y; Ishigaki T; Abe M; Tamaki N; Magata Y; Konishi J
J Nucl Med; 1993 Dec; 34(12):2124-9. PubMed ID: 8254399
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the biodistribution and PET imaging with (11)C-PDT and (18)F-FDG in the mouse model of lung adenocarcinoma].
Zhang T; Zhou NK; Zhang JM; Liang CY; Liu X; Tian XD
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):103-6. PubMed ID: 20403239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
